Gene: TLE1
Official Full Name: TLE family member 1, transcriptional corepressorprovided by HGNC
Gene Summary: Enables DNA-binding transcription factor binding activity; identical protein binding activity; and transcription corepressor activity. Involved in negative regulation of anoikis; negative regulation of signal transduction; and regulation of gene expression. Located in cytosol and nucleoplasm. Part of beta-catenin-TCF complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00184 | TLE1 Knockout cell line (HEK293) | Human | TLE1 | 1:3~1:6 | Negative | Online Inquiry |
KO00251 | TLE1 Knockout cell line (A549) | Human | TLE1 | 1:3~1:4 | Negative | Online Inquiry |
KO11651 | TLE1 Knockout cell line (HeLa) | Human | TLE1 | 1:3~1:6 | Negative | Online Inquiry |
KO11652 | TLE1 Knockout cell line (HCT 116) | Human | TLE1 | 1:2~1:4 | Negative | Online Inquiry |
TLE1 Gene Knockout Cell Lines are specifically engineered cell lines that feature precise deletions of the TLE1 gene, which encodes for the TLE1 protein, a key scaffold protein involved in regulating various cellular processes, including cell differentiation and signaling pathways. These knockout cell lines serve as invaluable tools for elucidating the role of TLE1 in biological systems by allowing researchers to study its absence and the resultant phenotypic changes in cellular behavior.
The primary mechanism of action for TLE1 Gene Knockout Cell Lines lies in their ability to simulate a loss-of-function scenario in experimental setups. By eliminating the expression of TLE1, researchers can systematically investigate the downstream effects on signaling cascades and transcriptional activities, providing insights into developmental biology, cancer research, and other areas where TLE1 may play a significant role. This targeted approach aids in dissecting complex cellular networks and identifying potential therapeutic targets.
In terms of applications, these cell lines are particularly valuable in both research and clinical settings. Their use accelerates the understanding of TLE1's involvement in oncogenesis and other diseases, helping researchers identify potential biomarkers and therapeutic strategies. The capacity to model specific genetic alterations enhances the translational potential toward clinical applications.
A significant advantage of the TLE1 Gene Knockout Cell Lines is their reliability and reproducibility compared to alternative methods, such as temporary genetic knockdown techniques. Unlike transient methods that may not consistently suppress gene expression, these knockout lines provide a stable platform for long-term experimentation, ensuring that findings are robust and replicable.
For researchers and clinicians aiming to unlock the mysteries of gene function and its implications in health and disease, TLE1 Gene Knockout Cell Lines represent an essential resource. By employing these cell lines, users are equipped with a state-of-the-art tool to advance their studies in gene regulation and its related pathways effectively.
Our company specializes in providing high-quality biological products that enhance research capabilities, underscored by our commitment to scientific excellence and innovation in the field. With a focus on precision-engineered solutions, we stand at the forefront of supporting research endeavors with our cutting-edge offerings.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.